SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $4,752,644,375 |
| Positions | 148 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| AMGEN INC | AMGN | COM | $308,363,286 | 851,550 |
| VERTEX PHARMACEUTICALS INC | VRTX | COM | $287,424,867 | 578,634 |
| ARGENX SE | ARGX | SPONSORED ADR | $279,258,770 | 301,000 |
| GILEAD SCIENCES INC | GILD | COM | $272,739,254 | 2,158,772 |
| REVOLUTION MEDICINES INC | RVMD | COM | $196,272,062 | 1,048,014 |
| ORUKA THERAPEUTICS INC | ORKA | COM | $157,714,772 | 1,657,190 |
| INSMED INC | INSM | COM PAR $.01 | $148,566,227 | 1,393,418 |
| SCHOLAR ROCK HLDG CORP | SRRK | COM | $134,725,085 | 2,449,547 |
| NUVALENT INC | NUVL | COM | $130,078,598 | 1,053,268 |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $123,665,169 | 6,731,909 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.